• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
US Epilepsy Market Highlights - 2014 Product Image

US Epilepsy Market Highlights - 2014

  • ID: 2855234
  • May 2014
  • Region: United States
  • Fore Pharma

The latest research, 'US Epilepsy Market Highlights – 2014', provides the US epilepsy market analysis, competitive landscape, and epilepsy drug sales forecast in the US.
The research includes the US epilepsy market size estimates for 2013, market share forecast for six years to 2019, epilepsy drugs market share, epilepsy drugs sales estimates, epilepsy drugs sales forecast, and epilepsy late stage pipeline products.
This research helps executives track competitor drugs sales and market share in the US epilepsy market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US epilepsy market.

SCOPE OF THE REPORT
- What are the drugs marketed in the US for treating epilepsy?
Identify drugs marketed in the US for treating epilepsy including trade name, molecule name, company, and year of launch.

- How big is the US epilepsy market?
Find out estimates for the US epilepsy market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our READ MORE >

Note: Product cover images may vary from those shown

1. Epilepsy - Disease Definition
2. Marketed Epilepsy Drugs in US
3. US Epilepsy Market Analysis
3a. US Epilepsy Market Size
3b. Drugs Sales in US Epilepsy Market
4. Competitive Landscape in US Epilepsy Market
4a. Drugs Market Share in US Epilepsy Market
4b. Generics Market Share in US Epilepsy Market
4c. Epilepsy Phase 3 Clinical Trial Pipeline Molecules
4c. Epilepsy Phase 2 Clinical Trial Pipeline Molecules
5. US Epilepsy Market – Future Market Outlook
5a. US Epilepsy Market Size Forecast
5b. Drug Sales Forecast in US Epilepsy Market
5c. Drugs Market Share in US Epilepsy Market
Table 1. Marketed Epilepsy Drugs in US, 2013
Table 2. US Epilepsy Market Size ($), 2010 – 2013
Table 3. Drugs Sales in US Epilepsy Market ($), 2013
Table 4. Epilepsy Phase 3 Clinical Trial Pipeline Molecules, 2014
Table 5: Epilepsy Phase 2 Clinical Trial Pipeline Molecules, 2014
Table 6. US Epilepsy Market Forecast ($), 2013 – 2019
Table 7: Drug Sales Forecast in US Epilepsy Market ($), 2013 – 2019
Figure 1. US Epilepsy Market Size ($), 2010 – 2013
Figure 2. Drugs Market Share in US Epilepsy Market (%), 2013
Figure 3. US Epilepsy Market Forecast ($), 2013 – 2019
Figure 4. Drugs Sales Forecast in US Epilepsy Market ($), 2013 – 2019
Figure 5: Drugs Market Share in US Epilepsy Market (%), 2019

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos